Skip to main content
Screener/Healthcare/Biotechnology

OTLK — Outlook Therapeutics, Inc.

NASDAQ
$0.69+0.01 (+1.52%)
Micro CapPenny StockUnder $1Under $5Healthcare
$0.16
$2.54
$0.68
$0.71
EPS (TTM)$-1.62
P/E Ratio-0.15
Dividend Yield—
Market Cap$126.6M
Volume2.54M
Prev Close$0.68
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q2 '26$127.4B-$4.5T$-0.17-17.2%-3494.3%
Q1 '26-$1.2M-$23.1M$-0.38102.5%1908.8%
Q4 '25-$92K-$13.3M$-0.521098.5%14482.2%
Q3 '25$1.5M-$20.2M$-0.5570.8%-1338.8%
Q2 '25$0-$46.4M$-1.50——
Q1 '25$0$17.4M$0.72——
Q4 '24$170K$5.7M$0.3150.0%3345.2%
Q3 '24$0$44.4M$-0.89——
Get Your Daily Market Recap